SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-17-002515
Filing Date
2017-02-14
Accepted
2017-02-14 17:24:08
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 vktx-s3_20170214.htm S-3 541286
2 EX-5.1 vktx-ex51_7.htm EX-5 25899
3 EX-23.1 vktx-ex231_6.htm EX-23 3316
4 GRAPHIC g2017021321422389412693.jpg GRAPHIC 11200
5 GRAPHIC g2017021321422420312694.jpg GRAPHIC 17892
6 GRAPHIC g2017021321422518014238.jpg GRAPHIC 3305
7 GRAPHIC g2017021321422774514239.jpg GRAPHIC 3305
  Complete submission text file 0000950123-17-002515.txt   621289
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-216063 | Film No.: 17610544
SIC: 2834 Pharmaceutical Preparations